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REVIEW
NEUROTOXOCAROSIS
Josef FINSTERER(1) & Herbert AUER(2)
SUMMARY
Infection of humans with embryonated eggs of Toxocara canis (larva migrans) remains asymptomatic, or results in covert or
common toxocarosis, visceral larva migrans syndrome, or ophthalmologic and neurologic impairment. Though neurological
manifestations of Toxocara canis larvae are rare, toxocarosis remains an important differential diagnosis of various neurological
disorders. Manifestations of the central nervous system are dementia, meningo-encephalitis, myelitis, cerebral vasculitis, epilepsy,
or optic neuritis. Manifestations of the peripheral nervous system comprise radiculitis, affection of cranial nerves, or musculo-
skeletal involvement. If toxocarosis is neglected, ignored, or refused as a differential of these abnormalities, it may be easily
overlooked for years. Early recognition and treatment of the infection is, however, of paramount importance since it reduces
morbidity and mortality and the risk of secondary superinfection. Like the visceral manifestations, neurological manifestations of
toxocarosis are treated by benzimidazole components, most frequently albendazole, corticosteroids, or diethylcarbamazine. If
detected and treated early, the prognosis of neurological manifestations of toxocarosis is favourable.
KEYWORDS: Toxocarosis; Parasitosis; Nervous system; Infection; Larva migrans syndrome; Helminthosis; Albendazole.
INTRODUCTION
Despite increased knowledge about hygiene worldwide and
availability of potent anti-helminthic drugs, the prevalence of
helminthoses is still high. This is because of inappropriate application
of hygienic measures and because of the globalization and mobility,
which allows worldwide distribution of parasites also to the Western
world. One of the most frequently occurring helminthosis is the
infection with the larvae of the nematodes Toxocara canis and Toxocara
cati respectively [KAYES, 1997; MAGNAVAL et al., 2001]. Though
these parasites rarely affect the central or peripheral nervous system
(CNS, PNS), toxocarosis remains a differential diagnosis of various
neurological disorders. The following review gives an overview on the
current knowledge about the neurological implications of toxocarosis,
which are frequently overlooked if toxocarosis is neglected, ignored,
or refused as a differential. Early recognition and treatment of the
infection is of paramount importance since it reduces morbidity and
mortality and the risk of secondary superinfection [MAGNAVAL et
al., 2001].
HISTORY
Human infection with Toxocara canis has been first described in
the late fourties and early fifties. First evidence for CNS toxocarosis
has been given by BEAUTYMAN & WOOLF in 1951. On autopsy
they found a larva in the left thalamus of a child, whose death was
attributed to poliomyelitis [BEAUTYMAN & WOOLF, 1951]. In 1952
the term “visceral larva migrans syndrome” (VLM) was coined for
children with eosinophilia and long-term multi-system disease
[BEAVER et al., 1952]. Further evidence for CNS toxocarosis came
from a case report by DENT et al. in 1956. Also in 1956 the causative
organism of toxocarosis was detected [TAYLOR, 2001] and NICHOLS
et al., 1956 provided more data on the morphology of the worm and its
eggs and larvae. Since then several case studies and case reports and a
high number of animal studies has augmented the knowledge about all
aspects of toxocarosis, particularly about neurotoxocarosis. The term
covert toxocarosis was coined and defined by BASS et al. and TAYLOR
et al. in 1987. About 50 patients with CNS or PNS toxocarosis have
been reported so far.
INFECTIOUS AGENT AND WAY OF TRANSMISSION
Toxocarosis is caused by ingestion of the eggs of Toxocara canis,
a roundworm in dogs, puppies, and cats [GARCIA-PEDRIQUE, 2004;
PREISS, 1982]. The Toxocara roundworm is a nematode of the
Ascaridae family which normally parasites the small intestine of its
hosts [GLICKMAN & SCHANTZ, 1981; MAGNAVAL et al., 2001;
PECINALI et al., 2005]. Female worms produce up to 200000 eggs/d,
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which pass to the feces, are not infective, and require an incubation
period in the soil to embryonate [GLICKMAN & SCHANTZ, 1981].
Humans are accidentally infected by direct contact with dogs [WOLFE
& WRIGHT, 2003], ingestion of embryonated eggs from soil
(geophagia, pica), or after exposure to dirty hands (poor hygiene), raw
vegetables, or to larvae from undercooked giblets [NAGAKURA et
al., 1989; SALEM & SCHANTZ, 1992; XINOU et al., 2003]. After
ingestion embryonated eggs hatch in the intestines, larvae penetrate
the intestinal wall, and then migrate via the blood circulation to the
liver, lungs, and left heart, from where they disseminate via the systemic
circulation to eyes, brain, and muscle [DUNSMORE et al., 1983;
KAPLAN et al., 2004; MAGNAVAL et al., 2001]. Larvae do not grow
at these sites but become encapsulated by a collagenous reaction,
manifesting as eosinophilic granuloma, and are metabolically active
[XINOU et al., 2003]. They secrete an array of enzymes, waste products,
and cuticular components, which cause tissue damage, necrosis, and a
marked inflammatory reaction, with eosinophils as the major
component [XINOU et al., 2003]. There are indications that toxic
proteins from these eosinophils are released and contribute to the
pathology and symptomatology of toxocarosis [KAYES, 1997].
The migratory pathway of Toxocara canis larvae after oral ingestion
or artificial inoculation has been extensively studied in various animals.
According to these studies Toxocara canis embryonated eggs reach the
liver of NIH mice two days after infection and the lung three days after
oral infection [ABO-SHEHADA & HERBERT, 1984]. Also the kidneys
may be affected early. Larvae are then dispersed throughout the body and
enter the myotropic/neurotropic phase (affection of the CNS or
musculature) by day seven [ABO-SHEHADA & HERBERT, 1984;
PECINALI et al., 2005]. If larvae are experimentally injected into the
brain they are also capable of migrating from the brain to the viscera and
musculature. Considerable pathology occurs due to larval migration and
acute and chronic disease is recorded [ABO-SHEHADA & HERBERT,
1984]. There is a significant relation between the duration of infection,
inoculum size, and dispersal rate of the larvae [EL-SHAZLY et al., 1991].
EPIDEMIOLOGY
As many as one billion humans are infected with animal parasites
[DONOVICK AND BURRIGHT, 1987]. One of the most prevalent is
Toxocara canis [MAGNAVAL et al., 2001]. The seroprevalence is
particularly high in developing countries, especially in rural areas, and
also some tropical islands [XINOU et al., 2003]. Human toxocarosis
is predominantly frequent in areas where the stray and Toxocara canis
infected dog population is big [KAPLAN et al., 2004]. The prevalence
of Toxocara canis infections in dogs is variable and amounts to 4.3%
in Japan [ITOH et al., 2004], 17% in Austria, or 66% in the USA
[DONOVICK & BURRIGHT, 1987]. Particularly, in many rural areas
worldwide infection rates may be even higher. Additionally, 40% of
the foxes and up to 67% of the cats are infected in Austria [AUER &
ASPÖCK, 1998]. An area is considered to pose a high risk for Toxocara
canis infection when the infection rate among dogs is > 7% [XINOU
et al., 2003]. There is a strong correlation between the infectious risk,
life style and Toxocara sero-prevalence. Children are more frequently
affected than adults [GARCIA-PEDRIQUE et al., 2004]. On the
average, 7% of all humans carry antibodies against Toxocara canis
[DONOVICK AND BURRIGHT, 1987], but there is a broad range
depending on the tested location [DE ANDRADE LIMA COELHO et
al., 2005; GARCIA-PEDRIQUE et al., 2004; AGUIAR-SANTOS et
al., 2004]. From Reunion a seroprevalence of 93% in adults and from
Saint-Lucia a seroprevalence of 86% in children has been reported
[THOMPSON et al., 1986]. In a study on mountain aboriginal
schoolchildren in Taiwan the overall seroprevalence of toxocarosis was
77% [FAN et al., 2004]. In Bali a seroprevalence of 63% has been
found [MAGNAVAL et al., 1994]. In a study on 386 Brazilian children
the frequency of IgG antibodies against Toxocara was 39% [AGUIAR-
SANTOS et al., 2004]. Intestinal helminths were present in 52% of
individuals that underwent coprological examination [AGUIAR-
SANTOS et al., 2004]. In another Brazilian study the frequency of
positive serology for toxocara was 30% [MOREIRA-SILVA et al.,
2004]. In a study on 150 Lebanese subjects the seroprevalence was
19% [KANAFANI et al., 2006]. The annual incidence rate in a study
on 75 individuals from the São Paulo area was 18% [ANARUMA
FILHO et al., 2003].
VISCERAL MANIFESTATIONS
Humans who ingest Toxocara canis eggs may remain unaffected or
may manifest a mono- or multi-system disease with symptoms arising
from larval invasion of different organs [BACHLI et al., 2004;
RUTTINGER & HADIDI, 1991]. The degree of host damage is dependent
on the tissue affected, the number of migrating juveniles, the level of
immunocompetence, and the host’s age [DESPOMMIER, 2003].
Additionally, pathological consequences are dependent on the death of
the juveniles [DESPOMMIER, 2003]. Death of larvae induces
immediate-type and delayed-type hypersensitivity responses. Immediate-
type hypersensitivity responses manifest clinically as classical VLM
[DESPOMMIER, 2003]. The organs most frequently affected are the
liver, lungs, eyes, CNS, myocardium, or musculature
[HARALAMBIDOU et al., 2005; RUTTINGER & HADIDI, 1991].
Accordingly, toxocarosis can be classified as: 1. Classical or incomplete
VLM. 2. Neurological toxocarosis, including ocular involvement (ocular
larva migrans syndrome). 3. Covert or common toxocarosis [TAYLOR
et al., 1987]. 4. Asymptomatic toxocarosis [AUER & ASPÖCK, 2004;
BASS et al., 1987; HAYASHI et al., 2003; TAYLOR et al., 1987;
TRABELSI et al., 2004]. In the majority of the cases, Toxocara canis
infection remains clinically unapparent. Covert toxocarosis is present
when in patients with only mild, focal impairment without systemic
manifestations, toxocarosis remains unrecognized [AUER & ASPÖCK,
2004; KAWAJIRI et al., 2001]. Overt toxocarosis usually manifests in
children as fever, anorexia, vomiting, lethargy, sleep and behavior
disorders, pharyngitis, pneumonia, cough, wheeze, limb pain, cervical
lymphadenitis, or hepatomegaly [MAGNAVAL et al., 2001]. Common
toxocarosis is only loosely related to a clinical form but is most frequently
associated with weakness, pruritus, rash, impaired breathing, and
abdominal pain [MAGNAVAL et al., 2001]. VLM is usually seen in
preschool children [PREISS, 1982] and characterized by general illness
with fever, skin rash, abdominal symptoms due to hepatomegaly or
splenomegaly, respiratory symptoms (particularly bronchospasm) due
to pulmonary infiltrations, myalgias, arthralgias, anorexia, persistent
eosinophilia of more than 30%, leucocytosis, and hyper-
gammaglobulinemia [BARRA et al., 1996; OTA et al., 1994; PREISS,
1982; PECINALI et al., 2005; XINOU et al., 2003]. In the liver of patients
with VLM granulomatous lesions can be found [HILL et al., 1985;
LEONE et al., 2005]. In rare cases toxocarosis may manifest as colicky
abdominal pain and ascites [CHIRA et al., 2005]. VLM usually results
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in a benign self-limited course [MOREIRA-SILVA et al., 2004].
Toxocarosis has been also associated with allergy-related syndromes,
like chronic urticaria, reactive arthritis, or angioedema [ISMAIL &
KHALAFALLAH, 2005; MAGNAVAL et al., 2001].
NEUROLOGICAL MANIFESTATIONS
A) CNS involvement: CNS involvement due to Toxocara sp. has
been documented only in about 50 patients [BACHLI et al., 2004;
BOUCHARD et al., 1998; GOFFETTE et al., 2000; HUISMANS, 1980;
MOREIRA-SILVA et al., 2004; OSOEGAWA, 2004] although in
experimental animals larva migrans frequently migrates to the brain
[FAN et al., 2003; GOOD et al., 2001; COX & HOLLAND, 1998].
The exact frequency of CNS involvement in toxocarosis is unknown
and varies with different species of migrating larvae [MOREIRA-SILVA
et al., 2004]. In a study on 308 autopsies of children the frequency of
CNS granulomas due to larva migrans was 0.68%. In another study
epilepsy was found in 5% of the patients with VLM [LEWIS et al.,
1962]. Other studies however, showed that toxocara infection is
frequently not associated with obvious neurological abnormalities
although antibodies against Toxocara canis were repeatedly found in
the CSF of these patients [MOREIRA-SILVA et al., 2004].
The site of the CNS invasion depends on multiple factors, like
number of ingested larvae, genetic factors of the host, and whether
previous exposure had occurred [XINOU et al., 2003]. CNS
involvement comprises meningitis [ENGEL et al., 1971; MOREIRA-
SILVA et al., 2004; OSOEGAWA, 2004], encephalitis [MOREIRA-
SILVA et al., 2004; OTA et al., 1994], myelitis [ENGEL et al., 1971;
GOFFETTE et al., 2000; KAWAJIRI et al., 2001; OSOEGAWA, 2004;
OTA et al., 1994; SELLAL et al., 1992; YOSHIDA et al., 2004], cerebral
vasculitis [DOUSSET et al., 2003], or optic neuritis [HAYASHI et al.,
2003; KOMIYAMA et al., 1995] (Table 1). CNS toxocarosis is related
to the number of larvae entering the brain and to the severity of CNS
damage and inflammation [XINOU et al., 2003]. Following these
manifestations, affected patients complain about headache, fever, over-
sensitivity to light, weakness, dorsalgia, confusion, tiredness, and visual
impairment. In mice behavioral changes have been reported and were
related to the number of larvae accumulated in the brain [COX &
HOLLAND, 1998; HAMILTON et al., 2006; SKERRETT &
HOLLAND, 1997]. Despite the identification of the risk factors rural
residence, ownership of dogs, and dementia for CNS toxocarosis by a
multivariate logistic regression analysis, a recognizable neurologic
defect has not been identified [MAGNAVAL et al., 1997]. Most of the
cases with CNS toxocarosis on autopsy did not present with clinical
CNS manifestations [MOREIRA-SILVA et al., 2004]. CNS toxocarosis
may occur at all ages and it appears that there is no gender
preponderance [MOREIRA-SILVA et al., 2004]. There may be
eosinophilia exclusively in the CSF and vice versa focal CNS lesions
with blood eosinophilia but normal CSF findings [VIDAL et al., 2003],
why a negative spinal tap does not rule out CNS toxocarosis. In animals
CNS toxocarosis manifested as cerebellar ataxia [AKAO et al., 2003].
1. Dementia: Dementia and depression have been reported only in
a single patient as a manifestation of CNS toxocarosis [RICHARTZ &
BUCHKREMER, 2002]. In a 65-year-old woman with a long-lasting
history of depression and cognitive decline CSF investigations revealed
eosinophilia and antibodies against Toxocara canis antigen. Treatment
with albendazole improved the cognitive deficits. The infection was
assumed to have occurred years before when the woman was working
as a shepherd in close contact with dogs [RICHARTZ &
BUCHKREMER, 2002]. Even if the infection had occurred already
years before the clinical manifestations, affected patients may profit
from specific anti-helminthic therapy [RICHARTZ & BUCHKREMER,
2002]. CNS toxocarosis may also manifest as behavioral disturbances
[CRITCHLEY et al., 1982]. In a study on 155 children seropositivity
to Toxocara was associated with adverse neuropsychological effects
[MARMOR et al., 1987]. In a study on 77 children seropositivity was
associated with poor reading achievement, marked distractibility, and
lower intelligence [WORLEY et al., 1984].
2. Eosinophilic meningo-encephalitis: Eosinophilic encephalitis
is a rare manifestation of a Toxocara canis infestation and has been
reported in single patients [BARRA et al., 1996; GOULD et al., 1985;
MIKHAEL et al., 1974; MIMOSO et al., 1993; MRISSA et al., 2005;
SOMMER et al., 1994; VILLANO et al., 1992]. In a 21-year-old woman
eosinophilic meningo-encephalitis manifested as frontal headache,
fever, ataxia, meningeal irritation, epilepsy, and pleocytosis [OTA et
al., 1994]. She had been in close contact with a dog. Cerebral MRI
showed several T2-hyperintense cortical and subcortical lesions, which
enhanced with gadolinium [OTA et al., 1994]. Antibodies against the
Toxocara canis antigen were positive in the serum and CSF. Under a
therapy with diethyl-carbamazine and corticosteroids the manifestations
resolved [OTA et al., 1994]. In a 2-year-old boy with headache,
Table 1
Neurological manifestations of toxocarosis
Central nervous system Reference
Cerebral vasculitis DOUSSET et al., 2003; OUJAMAA et al., 2003
Eosinophilic meningitis GOFETTE, 2000; MOREIRA-SILVA et al., 2004; OTA et al., 1994; VIDAL et al., 2003
Eosinophilic encephalitis MOREIRA-SILVA et al., 2004; VIDAL et al., 2003
Eosinophilic myelitis GOFETTE et al., 2000; MOREIRA-SILVA et al., 2004; OLSON & PETTEWAY, 1972
Epilepsy BACHLI et al., 2004; ARPINO et al., 1990; NICOLETTI et al., 2002
Optic neuritis HAYASHI et al., 2003; KOMIYAMA et al., 1995
Peripheral nervous system
Radiculitis MOREIRA-SILVA et al., 2004
Skeletal muscle affection SUGANE & OSHIMA, 1982
7th cranial nerve affection personal communication
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confusion, weakness, clinical neurologic examination revealed lethargy,
irritability, nuchal rigidity, weakness and accentuated deep tendon
reflexes, extensive diagnostic work-up disclosed eosinophilic
pleocytosis, and antibody testing revealed a Toxocara canis infection
[VIDAL et al., 2003]. In a 54-year-old female encephalitis manifested
on cerebral MRI as several enhancing subcortical white matter lesions
in both lobes [XINOU et al., 2003]. A 48-year-old patient with Toxocara
canis encephalitis presented with ataxia, rigor, and neuropsychological
disturbances [SOMMER et al., 1994]. Imaging studies revealed diffuse,
circumscribed white matter lesions and occlusion of various branches
of the middle cerebral artery [SOMMER et al., 1994]. Antihelminthic
therapy was only initially effective and, because of progression, had to
be enhanced by corticosteroids and azathioprine [SOMMER et al.,
1994]. Cerebral lesions of toxocarosis locate predominantly in the
cerebral and cerebellar white matter with or without the presence of
larvae [KAYES & OAKS, 1978]. The presence or absence of larvae
within these lesions is due to the fact that larvae are not permanently
trapped by the host reaction but can escape from the reaction, migrate
elsewhere and elicit the same reaction anew [XINOU et al., 2003].
This is why the cellular composition of granulomas does not indicate
the length of the infection [KAYES & OAKS, 1978].
3. Myelitis: Affection of the myelon by the larvae has been repeatedly
reported [DAURIAC-LE MASSON et al., 2005; GOFETTE et al., 2000],
usually in association with encephalitis or meningitis [EBERHARDT et
al., 2005; ENGEL et al., 1971] but also isolated [SELLAL et al., 1992].
In a 40-year-old woman, eosinophilic myelitis resulted in subacute
weakness of the right leg and dysesthesias in the dermatomas Th8-10.
MRI studies of the myelon revealed an abnormal hyperintensity within
the spinal cord and CSF investigations revealed eosinophilic pleocytosis
[GOFETTE et al., 2000]. The neurological abnormalities resolved
completely after mebendazole therapy [GOFETTE et al., 2000]. In a
young woman recurrent myelitis was attributed to larva migrans infection
after detection of eosinophilia in the serum and CSF, antibodies against
Toxocara and a favorable response to diethylcarbamazine (DEC)
[SELLAL et al., 1992]. Meningo-myelitis was also reported by others
[DAURIAC-LE MASSON et al., 2005; ENGEL et al., 1971; SELLAL
et al., 1992]. In these reports spinal MRI showed solitary or multiple,
strongly and homogeneously enhancing T2-hyperintense lesions
[DUPREZ et al., 1996; GOFETTE et al., 2000; KUMAR & KIMM,
1994; STRUPP et al., 1999]. In most of these cases the CNS was the
organ exclusively affected by the infection [XINOU et al., 2003]. Some
Japanese cases presented with sensory disturbances (positive Lhermitte
sign, paresthesias, hyperesthesia), extensive, enhancing spinal cord
lesions on T2-weighted MR images, and mild CSF eosinophilia
[OSOEGAWA, 2004]. In a 27-year-old woman Toxocara canis myelitis
manifested as back pain, positive Lhermitte sign, mild blood eosinophilia,
mildly increased IgE levels, and CSF eosinophilia. In a single case
toxocarosis manifested as spinal dural abscess [RUSSEGGER &
SCHMUTZHARD, 1987].
4. Cerebral vasculitis: Only single angiographically documented
cases with cerebral vasculitis have been reported [DOUSSET et al.,
2003; HAMIDOU et al., 2002; OUJAMAA et al., 2003; SOMMER et
al., 1994]. In one of these cases occlusion of multiple small branches
of the middle cerebral artery with multiple consecutive brain infarcts
has been found. Cerebral infarction close to the cerebral granulomas
was also detected in another case [XINOU et al., 2003]. Cerebral
vasculitis may even develop during antihelminthic treatment. Whether
infarctions in these cases were due to the acute inflammatory reaction
against the antigen or due to a delayed-type hypersensitivity to
antihelminthic therapy remains questionable [XINOU et al., 2003].
5. Epilepsy: There are several reports showing an association
between a positive Toxocara canis serology and seizures [ARPINO et
al., 1990; NICOLETTI et al., 2002; OTA et al., 1994]. There are
estimations according to which 12000-15000 of epilepsy cases in
Britain are attributable to CNS toxocarosis [PIEKARSKI, 1987]. In
another study epilepsy was found in three of 58 patients with VLM
[LEWIS et al., 1962]. Seizures have been reported as the initial CNS
manifestation of toxocarosis in quite a number of patients [BACHLI
et al., 2004]. In an 11-year-old girl with generalized epileptic seizures
due to a focal cerebral mass lesion and blood eosinophilia, toxocarosis
was diagnosed after resection of the lesion [BACHLI et al., 2004].
After albendazole the patient recovered completely without sequelae.
6. Optic neuropathy: Ocular abnormalities are a frequent
complication of toxocarosis. Ocular Toxocara canis infection usually
manifests as visual loss from optic neuritis when there is simultaneous
cerebral toxocarosis [KOMIYAMA et al., 1995]. Uveitis, or chorio-
retinitis may also occur [MACARIE et al., 2005; STEWART et al.,
2005]. Toxocara canis uveitis usually manifests unilaterally and may
present as peripheral granuloma of the retina, papillitis, macular
granuloma, or as vitreous inflammation, mimicking endophthalmitis
[STEWART et al., 2005]. Secondary glaucoma can follow
[DESPOMMIER, 2003]. In a study on 68 patients with posterior pole
granuloma antibodies against Toxocara were detected in 17% of them
[MIRDHA & KHOKAR, 2002]. According to findings in Mongolian
gerbils, a useful animal model for toxocarosis, larvae migrate from
the cerebrum to the eye through the optic nerve arriving there by day
nine after inoculation [HAYASHI et al., 2003]. Other studies
demonstrated ocular affection by the infection already three days after
oral infection [HAYASHI et al., 2003]. According to these data there
are two migration pathways to the retina in ocular toxocarosis, an early
hematogenic pathway and a late pathway along the optic nerve
[HAYASHI et al., 2003].
B) Peripheral nervous system involvement: PNS manifestations
of toxocarosis are rare and comprise radiculitis, affection of cranial
nerves, or musculo-skeletal involvement. However, PNS manifestations
are presumably more frequent than previously reported.
1. Radiculitis: Radiculitis is a rare manifestation of neurotoxo-
cariasis and usually occurs together with meningitis [ROBINSON et
al., 2002]. The diagnosis is based on the clinical findings (reduced
tendon reflexes, muscle weakness, muscle wasting fasciculations), CSF
findings (eosinophilia, positive antibodies against Toxocara canis
antigen), and abnormal nerve conduction studies (abnormal F-wave
studies, proximal neuropathy), or electromyography (neurogenic
electromyogram).
2. Cranial nerves other than the optic nerve: Larva migrans of
Toxocara canis involving cranial nerves almost exclusively concerns
the optic nerve [HAYASHI et al., 2003]. Larva migrans of Toxocara
canis associated with affection of other cranial nerves has not been
reported but peripheral facial palsy with atypical facial pain and swollen
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cervical lymph nodes may be a rare PNS manifestation of toxocarosis
[personal communication]. In a patient with a peripheral seventh cranial
nerve palsy diagnostic work-up revealed antibodies against Toxocara
canis in the CSF. This patient profited shortly from a therapy with
albendazole. That he did not develop neurological abnormalities other
than the cranial nerve palsy is surprising, but may be attributed to the
generally mild CNS manifestations of neurotoxocarosis. Obviously,
more patients than assumed carry larvae but do not develop clinical
neurological manifestations of the disease. Arguments for CNS
toxocarosis in this case were the presence of Toxocara canis antibodies
in the CSF, and bilaterally enlarged cervical lymph nodes.
Transmigration of serum Toxocara canis antibodies via the blood brain
barrier into the CSF is rather unlikely given the absence of any reports
confirming such a scenario. On the other hand absence of pleocytosis
and eosinophilia in the CSF does not exclude CNS toxocarosis,
particularly after three previous albendazole cycles and the presumably
long interval between the acute infection and antibody determination.
Also repeatedly normal imaging studies of the brain do not exclude
CNS toxocarosis. Assuming CNS toxocarosis as the cause of a Bell’s
palsy, either the infundibular (intracerebral) portion of the nerve must
have been affected from focal encephalitis, meningitis, or radiculitis,
or the larvae infiltrated the nerve and migrated centrifugally.
3. Skeletal muscle involvement: Migration of larva migrans to
the musculature has been only rarely reported in humans [RAYES &
LAMBERTUCCI, 1999; RAYES et al., 2000; SUGANE & OSHIMA,
1982]. Usually, muscular toxocarosis manifests as pyomyositis,
accompanied by the development of muscular abscesses, granuloma
formation around larvae, and tissue necrosis [RAYES &
LAMBERTUCCI, 1999; SUGANE & OSHIMA, 1982]. In single cases
muscular affection may also manifest as focal myositis, resulting in
unilateral swelling of a leg [WALSH et al., 1988] or as severe necrotic
pyomyositis, requiring urgent surgical debridement [LAMBERTUCCI
et al., 1998]. In mice however, affection of the skeletal muscles by the
infection is a frequent finding [FAN et al., 2003].
Diagnosis: Diagnosis of CNS and PNS involvement of toxocarosis
is based on the history, the clinical neurologic investigation, blood
tests, including differential blood cell count, and CSF investigations,
including determination of antibodies against Toxocara canis antigen
in the CSF, and imaging methods, including cerebral CT scans, cerebral
MRI, and cerebral angiography. PNS involvement can be recognized
when applying nerve conduction studies, F-wave studies,
electromyography, CSF investigations, or muscle/nerve biopsy.
Granuloma formation around larvae within the skeletal muscle can
also be detected by imaging methods like ultrasound, CT, or MRI of
the muscle [SUGANE & OSHIMA, 1982]. Since the prevalence of
toxocarosis is high in patients with unknown eosinophilia, these patients
should undergo antibody testing [KWON et al., 2006]. Generally, the
diagnosis of neurotoxocarosis requires the following findings: 1. High
titres of Toxocara canis antibodies in the serum. 2. High titers of
Toxocara canis antibodies in the CSF. 3. Eosinophilia in the serum or
CSF. 4. Clinical and radiologic improvement and normalization of CSF
abnormalities upon anti-helminthic therapy [XINOU et al., 2003].
1. Blood chemical investigations: Eosinophilia can be almost
always found in VLM, but may be absent in single patients with covert
or common toxocarosis [MAGNAVAL et al., 2001]. On the contrary,
in ocular or CNS toxocarosis eosinophilia is frequently absent
[MAGNAVAL et al., 2001]. Another promising diagnostic parameter
is elevated serum IgE [MAGNAVAL et al., 2001]. The most commonly
used diagnostic test is the ELISA with TES-antigen. A positive ELISA
can be confirmed by Western blot [MAGNAVAL et al., 2001], which
is as sensitive as the ELISA and quite specific [MAGNAVAL et al.,
2001]. Concerning the interpretation of the serological results,
individuals with positive antibodies but absent clinical manifestations
rather represent past than present infection [MAGNAVAL et al., 2001].
Seropositivity associated with eosinophilia, however, indicates active
toxocarosis. In patients with covert or common toxocarosis but absent
eosinophilia, increase in IgE provides evidence for active toxocarosis
[MAGNAVAL et al., 2001]. Care must be taken concerning the
reliability of Toxocara canis antibody titers in the serum and even
CSF, since they are often normal or borderline, particularly in patients
with sole CNS manifestations [XINOU et al., 2003].
2. Radiological investigations: Cerebral MR images show cortical
or sub-cortical, multifocal, circumscribed, homogeneously enhancing
T2-hyperintense lesions or a combination of circumscribed and diffuse
changes [KOMIYAMA et al., 1995; RUTTINGER & HADIDI, 1991;
SOMMER et al., 1994; ZACHARIAH et al., 1994]. These lesions are
hypodense on cerebral CT and hypointense on T1-weighted MR images.
Along with the CNS inflammation, areas of hemorrhage can be detected
[XINOU et al., 2003]. Occasionally, there is focal meningeal
enhancement suggesting extension of the inflammation to the
subarachnoidal space [XINOU et al., 2003]. T1- and T2-hyperintense
cortical areas are interpreted as cortical necrosis, presumably due to
multiple brain infarcts caused by immune vasculitis [XINOU et al.,
2003]. Generally, cerebral CT and MRI findings in neurotoxocarosis
are non-specific and for establishing the diagnosis the above mentioned
criteria need to be fulfilled. Serial MR imaging studies, however, are a
valuable tool to monitor the disease course. In case of myelitis spinal
MRI may show enhancing T2-hyperintensities [OSOEGAWA, 2004].
Differential diagnoses: Toxocarosis is not the only helminthic
infection, which causes eosinophilic meningo-encephalitis.
Eosinophilic meningo-encephalitis may also occur together with
infections from Baylisascaris procyonis, Gnathostoma spinigerum,
Angiostrongylus cantonensis, Coccidioides immitis, or together with
cysticercosis, ascaridiosis, trichinosis, strongyloidosis, echinococcosis,
schistosomiosis, paragonimiosis, or fascioliosis [VIDAL et al., 2003].
Transient CSF eosinophilia can be also observed in tuberculosis,
syphilis, or lymphoma involving the meninges [VIDAL et al., 2003].
Therapy: There is a general lack of well-controlled studies on the
therapy of neurotoxocarosis, being attributed to the rarity of the disease.
Amongst all available drugs albendazole is the most commonly used
and the treatment of choice [PAWLOWSKI, 2001]. However, other
benzimidazole components, like oxibendazole, flubendazole, or
thiabendazole [FOK & KASSAI, 1998; LEONE et al., 2005] have a
similar effect [PAWLOWSKI, 2001]. Positive experiences also exist with
DEC [REY et al., 2005]. Concerning the efficacy of ivermectin, it cannot
be recommended for human toxocarosis at the moment [MAGNAVAL
et al., 2001]. The blood-brain barrier is principally permeable for all
available antihelminthic drugs [FOK & KASSAI, 1998], but
benzimidazoles other than albendazole are poorly absorbed outside the
gastrointestinal tract. Administration of albendazole three times per day
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is more effective than a single daily dose [DELGADO et al., 1989].
Albendazole gives better results than other antihelminthic drugs, because
it reaches higher serum concentrations, has a better penetration into the
CSF, and is less toxic [VIDAL et al., 2003]. Neurotoxocarosis may also
resolve from thiabendazole [RUSSEGGER & SCHMUTZHARD, 1987]
or DEC [RUTTINGER & HADIDI, 1991] alone, or from a combination
of corticosteroids with DEC [KOMIYAMA et al., 1995], corticosteroids
and mebendazole [DUPREZ et al., 1996], or corticosteroids and
thiabendazole [KUMAR & KIMM, 1994].
In case of ocular involvement the additional administration of
corticosteroids is recommended [RICHARTZ & BUCHKREMER,
2002]. Particularly, the Toxocara canis optic neuropathy is sensitive to
corticosteroids [COX et al., 1993]. Except for ophthalmologic
toxocarosis there is no consensus concerning the utility of
corticosteroids for CNS toxocarosis [VIDAL et al., 2003].
Corticosteroids administered during Toxocara canis infestation may
even result in a significant increase in brain parasitism and total larval
count [MOHAMED et al., 1994]. If Toxocara canis endophthalmitis
is non-responsive to the common surgical and medical approach
(vitrectomy, antihelminthics, corticosteroids) cyclosporine A may be
helpful [BARISANI-ASENBAUER et al., 2001; MORA et al., 2005;
LESCANO et al., 2004].
Administration of specific antihelminthic drugs for CNS
toxocarosis usually resolves the clinical neurologic impairment, but
morphological lesions, found on imaging studies, only rarely decrease
in size or number [RUTTINGER AND HADIDI, 1991]. Several
experimental approaches resulted in promising results, like the glucan
immunemodulator combined with immunoglobulin and zinc [SOLTYS
et al., 1996]. In addition to the pharmacological treatment, CNS
toxocarosis requires thorough prevention of recontamination by
deworming dogs and sanitary education [MAGNAVAL et al., 2001].
CONCLUSIONS
Toxocara canis infestation is a worldwide problem and manifests
as VLM, ocular larva migrans syndrome, covert toxocarosis or common
toxocarosis or remains asymptomatic. Rarely, CNS and PNS are
involved, manifesting as encephalopathy with cognitive decline,
meningo-encephalitis, cerebral vasculitis, epilepsy, visual impairment,
myelitis, radiculitis, cranial nerve involvement, or skeletal muscle
affection. Transmission from animal to human is favored by the
cohabitation with dogs and cats, poor hygiene, and by frequenting public
parks and playgrounds. Prophylactic measures aim to limit access to
contaminated soil, to regularly deworm pets, to reduce the number of
domestic animals, and to limit their access to areas frequented by young
children. Future control programs require cheap and effective diagnostic
approaches, the development of vaccines, which offer lifelong
protection, and effective and safe single-dose treatments. If detected
and treated early, the prognosis of neurological manifestations of
toxocarosis is favorable. Monitoring of CNS involvement in toxocarosis
is best carried out by repeated MRI investigations. Serial serum tests
for Toxocara antibodies are not useful for monitoring the disease course,
since they may remain positive for months or years, even after clinical
recovery. Blood eosinophilia should be thoroughly examined for
helminthosis. CSF eosinophilia is no prerequisite for CNS toxocarosis.
RESUMO
Neurotoxocaríase
Infecção humana com ovos embrionados de Toxocara canis (larva
migrans) pode permanecer assintomática ou resultar em toxocaríase
acentuada ou comum, síndrome da larva migrans visceral ou manifestações
neurológicas ou oftalmológicas. Embora manifestações neurológicas das
larvas de Toxocara canis sejam raras, a toxocaríase permanece como
importante diagnóstico diferencial de várias manifestações neurológicas.
Manifestações do sistema nervoso central são demência,
meningoencefalite, mielite, vasculite cerebral, epilepsia, ou neurite ótica.
Manifestações do sistema nervoso periférico compreendem radiculite,
agressão de nervos cranianos ou envolvimento músculo-esquelético. Se a
toxocaríase é negligenciada, ignorada, ou recusada como diferencial destas
anormalidades, ela pode ser facilmente desapercebida por anos.
Reconhecimento precoce de tratamento da infecção é portanto de
fundamental importância uma vez que reduz sua morbidade e mortalidade
e o risco de superinfecção secundária. Da mesma maneira que as
manifestações viscerais, as neurológicas são tratadas por benzimidazólicos,
mais freqüentemente albendazole, corticosteróides ou dietilcarbamazine.
Se detectado e tratado precocemente, o prognóstico das manifestações
neurológicas da toxocaríase é favorável.
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